Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer.

van der Wekken AJ, Pelgrim R, 't Hart N, Werner N, Mastik MF, Hendriks L, van der Heijden EHFM, Looijen-Salamon M, de Langen AJ, Staal-van den Brekel J, Riemersma S, van den Borne BE, Speel EJM, Dingemans AC, Hiltermann TJN, van den Berg A, Timens W, Schuuring E, Groen HJM.

Clin Cancer Res. 2017 Aug 1;23(15):4251-4258. doi: 10.1158/1078-0432.CCR-16-1631. Epub 2017 Feb 9.

2.

Tumor Delineation and Quantitative Assessment of Glucose Metabolic Rate within Histologic Subtypes of Non-Small Cell Lung Cancer by Using Dynamic 18F Fluorodeoxyglucose PET.

Meijer TWH, de Geus-Oei LF, Visser EP, Oyen WJG, Looijen-Salamon MG, Visvikis D, Verhagen AFTM, Bussink J, Vriens D.

Radiology. 2017 May;283(2):547-559. doi: 10.1148/radiol.2016160329. Epub 2016 Nov 15.

PMID:
27846378
3.

Irreversible Respiratory Failure in a Full-Term Infant with Features of Pulmonary Interstitial Glycogenosis as Well as Bronchopulmonary Dysplasia.

Jiskoot-Ermers ME, Antonius TA, Looijen-Salamon MG, Wijnen MH, Loza BF, Heijst AF.

AJP Rep. 2015 Oct;5(2):e136-40. doi: 10.1055/s-0035-1551674. Epub 2015 Jun 3.

4.

Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma.

Schuurbiers OC, Meijer TW, Kaanders JH, Looijen-Salamon MG, de Geus-Oei LF, van der Drift MA, van der Heijden EH, Oyen WJ, Visser EP, Span PN, Bussink J.

J Thorac Oncol. 2014 Oct;9(10):1485-93. doi: 10.1097/JTO.0000000000000286.

5.

Non-resolving pneumonia in patient with obsessive--compulsive disorder.

Simons SO, Braam EA, de Boer RC, Looijen-Salamon M, Heijdra YF.

Thorax. 2014 Feb;69(2):193. doi: 10.1136/thoraxjnl-2013-203759. Epub 2013 Nov 1. No abstract available.

PMID:
24186920
6.

Mesenchymal cystic hamartoma? A revised diagnosis after 23 years.

van der Heijden EH, Kaal SE, Hassing HH, Verhagen AF, Looijen-Salamon M.

Thorax. 2014 Jan;69(1):84-5. doi: 10.1136/thoraxjnl-2013-204099. Epub 2013 Aug 29. No abstract available.

PMID:
23988750
7.

Mediastinal staging in daily practice: endosonography, followed by cervical mediastinoscopy. Do we really need both?

Verhagen AF, Schuurbiers OC, Looijen-Salamon MG, van der Heide SM, van Swieten HA, van der Heijden EH.

Interact Cardiovasc Thorac Surg. 2013 Nov;17(5):823-8. doi: 10.1093/icvts/ivt302. Epub 2013 Jul 9.

8.

Influence of lung injury on cardiac output measurement using transpulmonary ultrasound dilution: a validation study in neonatal lambs.

Vrancken SL, de Boode WP, Hopman JC, Looijen-Salamon MG, Liem KD, van Heijst AF.

Br J Anaesth. 2012 Dec;109(6):870-8. doi: 10.1093/bja/aes297. Epub 2012 Aug 19.

9.

EBUS and EUS guided fine needle aspirations for molecular diagnostic analysis in lung cancer.

van der Heijden HFM, Looijen-Salamon MG, Schuurbiers OCJ, Bussink J, Ligtenberg MJL.

Thorac Cancer. 2012 Aug;3(3):201-206. doi: 10.1111/j.1759-7714.2012.00116.x. Review.

PMID:
28920304
10.

EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma.

Smits AJ, Kummer JA, Hinrichs JW, Herder GJ, Scheidel-Jacobse KC, Jiwa NM, Ruijter TE, Nooijen PT, Looijen-Salamon MG, Ligtenberg MJ, Thunnissen FB, Heideman DA, de Weger RA, Vink A.

Cell Oncol (Dordr). 2012 Jun;35(3):189-96. doi: 10.1007/s13402-012-0078-4. Epub 2012 Apr 12.

11.

Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.

Meijer TW, Schuurbiers OC, Kaanders JH, Looijen-Salamon MG, de Geus-Oei LF, Verhagen AF, Lok J, van der Heijden HF, Rademakers SE, Span PN, Bussink J.

Lung Cancer. 2012 Jun;76(3):316-23. doi: 10.1016/j.lungcan.2011.11.006. Epub 2011 Dec 6.

PMID:
22153830
12.

Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined 18FDG-PET and contrast enhanced CT scanning.

Brocken P, Kiers BA, Looijen-Salamon MG, Dekhuijzen PN, Smits-van der Graaf C, Peters-Bax L, de Geus-Oei LF, van der Heijden HF.

Lung Cancer. 2012 Mar;75(3):336-41. doi: 10.1016/j.lungcan.2011.08.017. Epub 2011 Sep 22.

PMID:
21943652
13.

Talcosis due to abundant use of cosmetic talcum powder.

van Huisstede A, Noordhoek Hegt V, Otte-Holler I, Looijen-Salamon M, Rudolphus A.

Eur Respir Rev. 2010 Jun;19(116):165-8. doi: 10.1183/09059180.00001310. No abstract available.

14.
15.

The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours.

Dijkman BG, Schuurbiers OC, Vriens D, Looijen-Salamon M, Bussink J, Timmer-Bonte JN, Snoeren MM, Oyen WJ, van der Heijden HF, de Geus-Oei LF.

Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2037-47. doi: 10.1007/s00259-010-1505-2. Epub 2010 Jun 10.

16.

Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.

van der Aa MA, Schutter EM, Looijen-Salamon M, Martens JE, Siesling S.

Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):204-9. Epub 2008 Feb 21.

PMID:
18093720
17.

Acute, painful, and swollen testicle as the presenting feature in polyarteritis nodosa.

Susanto CR, Fedder G, Looijen-Salamon MG.

Eur J Intern Med. 2003 Nov;14(7):441-443.

PMID:
14614979

Supplemental Content

Loading ...
Support Center